Bausch Health Companies Inc (BHC)
8.62
+0.06
(+0.70%)
USD |
NYSE |
Apr 25, 16:00
8.46
-0.16
(-1.86%)
Pre-Market: 20:00
Bausch Health Cash from Operations (TTM): 1.032B for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.032B |
| September 30, 2023 | 1.117B |
| June 30, 2023 | -428.00M |
| March 31, 2023 | -511.00M |
| December 31, 2022 | -728.00M |
| September 30, 2022 | -1.179B |
| June 30, 2022 | 648.00M |
| March 31, 2022 | 920.00M |
| December 31, 2021 | 1.426B |
| September 30, 2021 | 1.796B |
| June 30, 2021 | 1.488B |
| March 31, 2021 | 1.293B |
| December 31, 2020 | 1.111B |
| September 30, 2020 | 951.00M |
| June 30, 2020 | 1.21B |
| March 31, 2020 | 1.349B |
| December 31, 2019 | 1.501B |
| September 30, 2019 | 1.586B |
| June 30, 2019 | 1.593B |
| March 31, 2019 | 1.476B |
| December 31, 2018 | 1.501B |
| September 30, 2018 | 1.76B |
| June 30, 2018 | 1.728B |
| March 31, 2018 | 1.774B |
| December 31, 2017 | 2.29B |
| Date | Value |
|---|---|
| September 30, 2017 | 2.224B |
| June 30, 2017 | 2.304B |
| March 31, 2017 | 2.484B |
| December 31, 2016 | 2.087B |
| September 30, 2016 | 2.172B |
| June 30, 2016 | 2.360B |
| March 31, 2016 | 2.323B |
| December 31, 2015 | 2.257B |
| September 30, 2015 | 2.493B |
| June 30, 2015 | 2.353B |
| March 31, 2015 | 2.319B |
| December 31, 2014 | 2.312B |
| September 30, 2014 | 1.759B |
| June 30, 2014 | 1.342B |
| March 31, 2014 | 1.271B |
| December 31, 2013 | 1.042B |
| September 30, 2013 | 830.04M |
| June 30, 2013 | 795.17M |
| March 31, 2013 | 744.67M |
| December 31, 2012 | 656.60M |
| September 30, 2012 | 778.44M |
| June 30, 2012 | 785.32M |
| March 31, 2012 | 721.37M |
| December 31, 2011 | 640.47M |
| September 30, 2011 | 449.29M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-1.179B
Minimum
Sep 2022
1.796B
Maximum
Sep 2021
851.32M
Average
1.117B
Median
Sep 2023
Cash from Operations (TTM) Benchmarks
| Acasti Pharma Inc | -13.57M |
| Aurinia Pharmaceuticals Inc | -33.46M |
| Edesa Biotech Inc | -6.252M |
| Lexaria Bioscience Corp | -5.209M |
| Xenon Pharmaceuticals Inc | -145.33M |